Skip to content
10-K/A

Annual Report

TriSalus Life Sciences, Inc. TLSI TLSIW

0001826667-25-000070

← back to feed
Filed
May 30, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 31, 2025 32.27M sh
Shares Diluted FY 2024 · Dec 31, 2024 25.33M sh
Shares Diluted FY 2024 · Dec 31, 2023 9.4M sh
Capex FY 2024 · Dec 31, 2024 $345K
Capex FY 2024 · Dec 31, 2023 $588K
Operating Cash Flow FY 2024 · Dec 31, 2024 −$40.84M
Operating Cash Flow FY 2024 · Mar 31, 2024 −$10.87M
Operating Cash Flow restated FY 2024 · Dec 31, 2023 −$50.58M
Long Term Debt FY 2024 · Dec 31, 2024 $22.08M
Long Term Debt FY 2024 · Dec 31, 2023 $0
Cash And Equivalents FY 2024 · Dec 31, 2024 $8.53M
Cash And Equivalents FY 2024 · Dec 31, 2023 $11.78M
Stockholders Equity FY 2024 · Dec 31, 2024 −$25.89M
Stockholders Equity restated FY 2024 · Dec 31, 2023 −$27.07M
Stockholders Equity restated FY 2024 · Dec 31, 2022 −$177.13M
Current Liabilities FY 2024 · Dec 31, 2024 $10.23M
Current Liabilities FY 2024 · Dec 31, 2023 $14.69M
Total Liabilities FY 2024 · Dec 31, 2024 $49.87M
Total Liabilities FY 2024 · Dec 31, 2023 $51.66M
Current Assets FY 2024 · Dec 31, 2024 $20.67M
Current Assets FY 2024 · Dec 31, 2023 $20.86M
Total Assets FY 2024 · Dec 31, 2024 $23.97M
Total Assets restated FY 2024 · Dec 31, 2023 $24.6M
Eps Diluted FY 2024 · Dec 31, 2024 −$1.31
Eps Diluted FY 2024 · Mar 31, 2024 −$0.60
Eps Diluted restated FY 2024 · Dec 31, 2023 −$6.77
Eps Basic FY 2024 · Dec 31, 2024 −$1.31
Eps Basic FY 2024 · Mar 31, 2024 −$0.60
Eps Basic restated FY 2024 · Dec 31, 2023 −$6.77
Sga Expense FY 2024 · Dec 31, 2024 $17.97M
Sga Expense FY 2024 · Dec 31, 2023 $23.51M
Rd Expense FY 2024 · Dec 31, 2024 $17.69M
Rd Expense FY 2024 · Mar 31, 2024 $5.84M
Rd Expense restated FY 2024 · Dec 31, 2023 $29.84M
Net Income FY 2024 · Dec 31, 2024 −$30.05M
Net Income FY 2024 · Mar 31, 2024 −$13.21M
Net Income restated FY 2024 · Dec 31, 2023 −$59.36M
Operating Income FY 2024 · Dec 31, 2024 −$36.17M
Operating Income FY 2024 · Mar 31, 2024 −$11.67M
Operating Income restated FY 2024 · Dec 31, 2023 −$54.48M
Gross Profit FY 2024 · Dec 31, 2024 $25.33M
Gross Profit FY 2024 · Dec 31, 2023 $15.91M
Cost Of Revenue FY 2024 · Dec 31, 2024 $4.1M
Cost Of Revenue FY 2024 · Dec 31, 2023 $2.61M
Revenue FY 2024 · Dec 31, 2024 $29.43M
Revenue FY 2024 · Dec 31, 2023 $18.51M